← Open Payments lookup

ANTHONY AEMMER: Open Payments

NPI 1659974806 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,014 in 186 payments from 18 companies in 2025. Trend: 2023 $1,416 · 2024 $2,560 · 2025 $3,014

Food & beverage: $2,903Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.18$511
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)33$436
Otsuka America Pharmaceutical, Inc.22$337
Neurocrine BioSciences, Inc.14$328
ABBVIE INC.38$284
E.R. Squibb & Sons, L.L.C.13$279
Alkermes, Inc.15$270
Lundbeck LLC14$224
Vanda Pharmaceuticals Inc.4$66
Janssen Pharmaceuticals, Inc3$62

Products named: CAPLYTA, ABILIFY ASIMTUFII, UZEDY, INGREZZA, COBENFY, VRAYLAR, REXULTI, ARISTADA.

Industry payments across IN — which companies pay providers there.